Trial shows new drug can slow down Alzheimer’s significantly
Eli Lilly, which developed the drug donanemab, said it can clear amyloid plaque from an Alzheimer’s patient’s brain in as early as six months. A new drug is being hailed as a “turning point” in the treatment of dementia after a global trial showed donanemab significantly slowed cognitive and…
#elililly #annewhite #society #wales #katelee #bbcnews #nhs #dailybrief #siliconrepublics #scitech